We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.1B
AUM Growth
-$1.32B
Cap. Flow
-$1.84B
Cap. Flow %
-12.19%
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$66.7M
2
MSCI icon
MSCI
MSCI
+$54.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
4
RMD icon
ResMed
RMD
+$44.7M
5
PPG icon
PPG Industries
PPG
+$43.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$74M
2
LHX icon
L3Harris
LHX
+$69.6M
3
HON icon
Honeywell
HON
+$64.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$60.2M
5
WFC icon
Wells Fargo
WFC
+$59.2M

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Consumer Discretionary 8.49%
3 Financials 8.33%
4 Industrials 8.18%
5 Healthcare 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFFSW
3326
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$4.05K ﹤0.01%
27,220
-900
-3% -$100
PARR icon
3327
Par Pacific Holdings
PARR
$3.59B
$3.96K ﹤0.01%
149
-315,747
-100% -$7.46M
RCUS icon
3328
Arcus Biosciences
RCUS
$3.66B
$3.84K ﹤0.01%
189
-67,841
-100% -$1.29M
UAVS icon
3329
AgEagle Aerial Systems
UAVS
$59.2M
$3.79K ﹤0.01%
+16
New +$5.72K
ROCLW
3330
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$3.78K ﹤0.01%
47,227
XHG
3331
XChange TEC
XHG
$49.1M
$3.74K ﹤0.01%
1
EVGRW
3332
DELISTED
Evergreen Corporation Warrant
EVGRW
$3.7K ﹤0.01%
122,580
EGIO
3333
DELISTED
Edgio, Inc. Common Stock
EGIO
$3.54K ﹤0.01%
+131
New +$3.1K
RACYW
3334
DELISTED
Relativity Acquisition Corp. Warrant
RACYW
$3.36K ﹤0.01%
71,250
BRD.WS
3335
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$3.29K ﹤0.01%
46,942
GTBP icon
3336
GT Biopharma
GTBP
$11.6M
$3.26K ﹤0.01%
+349
New +$3.62K
LIDR icon
3337
AEye
LIDR
$60.2M
$3.2K ﹤0.01%
+593
New +$3.68K
BKR icon
3338
Baker Hughes
BKR
$63.6B
$3.16K ﹤0.01%
100
-202,254
-100% -$5.9M
VBIO
3339
Valion Bio
VBIO
$1.2M
$3.03K ﹤0.01%
+17
New +$3.64K
HSDT icon
3340
Solana Company
HSDT
$99.3M
0
SIDU icon
3341
Sidus Space
SIDU
$238M
$2.75K ﹤0.01%
+152
New +$4.16K
SIX
3342
DELISTED
Six Flags Entertainment Corp.
SIX
$2.6K ﹤0.01%
+100
New +$2.59K
MYNA
3343
DELISTED
Mynaric AG American Depository Shares
MYNA
$2.54K ﹤0.01%
400
BIOL
3344
DELISTED
Biolase, Inc.
BIOL
$2.53K ﹤0.01%
+358
New +$5.99K
BMAC.WS
3345
DELISTED
Black Mountain Acquisition Corp. Warrants, exercisable for one share of Class A Common Stock
BMAC.WS
$2.4K ﹤0.01%
45,814
AACIW
3346
DELISTED
Armada Acquisition Corp. I Warrant
AACIW
$2.33K ﹤0.01%
21,064
-1,040
-5% -$99
BSLKW
3347
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$2.32K ﹤0.01%
77,273
TGVCW
3348
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$2.29K ﹤0.01%
101,885
+1,167
+1% +$45
ZCARW
3349
DELISTED
Zoomcar Holdings, Inc. Warrants
ZCARW
$2.24K ﹤0.01%
35,824
NVAX icon
3350
Novavax
NVAX
$1.3B
$2.24K ﹤0.01%
301
-52,746
-99% -$415K

Similar funds

Cubist Systematic Strategies's Q2 2023 Portfolio in Review

As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.

  • Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
  • Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
  • Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
  • Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
  • Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
  • Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.